Immunocore Holdings PLC (IMCR)

Sector:
HEALTH CARE
Industry:
BIOTECHNOLOGY & LIFE SCIENCES
SIC:
CEO:
Bahija Jallal
Employees:
291
90 PARK DRIVE, MILTON PARK, ABINGDON, OXFORDSHIRE, UNITED KINGDOM OX14 4RY
01235 5430281

Immunocore Holdings plc engages in the development of immunotherapies for the treatment of cancer, infectious, and autoimmune diseases. KIMMTRAK is in Phase I/II trials for patients with unresectable or metastatic uveal melanoma. The company's programs for infectious diseases include IMC-I109V, which is in a clinical trial in patients with chronic hepatitis B virus.

Data derived from most recent annual or quarterly report
Market Cap 2.305 Billion Shares Outstanding43.863 Million Avg 30-day Volume 203.243 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS
Price to Revenue3.1407 Debt to Equity1.1174 EBITDA-105.456 Million
Price to Book Value3.4177 Operating Margin-143.1112 Enterprise Value165.64 Million
Current Ratio2.781 EPS Growth0.401 Quick Ratio2.546
1 Yr BETA 1.1103 52-week High/Low 56.8 / 18.43 Profit Margin-123.0209
Operating Cash Flow Growth38.6516 Altman Z-Score-2.2249 Free Cash Flow to Firm -67.95 Million
View SEC Filings from IMCR instead.

Immunocore Holdings PLC YCharts
Yahoo! Finance finviz
SEC Web Site SEC DEF 14A Filings

Funds Holding IMCR (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
Click for Additional Filters
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding IMCR

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Financial Reporting

Ownership

Events (8k)

Proxy

Prospectus

All

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed		 Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
IMMUNOCORE HOLDINGS PLC-ADR IMCR 2022-08-12 22:15:03 UTC 1.8669 0.4531 400000
IMMUNOCORE HOLDINGS PLC-ADR IMCR 2022-08-12 21:45:04 UTC 1.8669 0.4531 400000
IMMUNOCORE HOLDINGS PLC-ADR IMCR 2022-08-12 21:15:04 UTC 1.8669 0.4531 400000
IMMUNOCORE HOLDINGS PLC-ADR IMCR 2022-08-12 20:45:04 UTC 1.8669 0.4531 400000
IMMUNOCORE HOLDINGS PLC-ADR IMCR 2022-08-12 20:15:05 UTC 1.8669 0.4531 400000
IMMUNOCORE HOLDINGS PLC-ADR IMCR 2022-08-12 19:45:03 UTC 1.8669 0.4531 400000
IMMUNOCORE HOLDINGS PLC-ADR IMCR 2022-08-12 19:15:05 UTC 1.8669 0.4531 400000
IMMUNOCORE HOLDINGS PLC-ADR IMCR 2022-08-12 18:45:03 UTC 1.8669 0.4531 400000
IMMUNOCORE HOLDINGS PLC-ADR IMCR 2022-08-12 18:15:04 UTC 1.8669 0.4531 400000
IMMUNOCORE HOLDINGS PLC-ADR IMCR 2022-08-12 17:45:04 UTC 1.8669 0.4531 400000
IMMUNOCORE HOLDINGS PLC-ADR IMCR 2022-08-12 17:15:05 UTC 1.8669 0.4531 400000
IMMUNOCORE HOLDINGS PLC-ADR IMCR 2022-08-12 16:45:04 UTC 1.7412 0.5788 400000
IMMUNOCORE HOLDINGS PLC-ADR IMCR 2022-08-12 16:15:04 UTC 1.7412 0.5788 400000
IMMUNOCORE HOLDINGS PLC-ADR IMCR 2022-08-12 15:45:04 UTC 1.7412 0.5788 300000
IMMUNOCORE HOLDINGS PLC-ADR IMCR 2022-08-12 15:15:05 UTC 1.7412 0.5788 300000
IMMUNOCORE HOLDINGS PLC-ADR IMCR 2022-08-12 14:45:04 UTC 1.7412 0.5788 300000
IMMUNOCORE HOLDINGS PLC-ADR IMCR 2022-08-12 14:15:05 UTC 1.7412 0.5788 300000
IMMUNOCORE HOLDINGS PLC-ADR IMCR 2022-08-12 13:45:04 UTC 1.6001 0.7199 300000
IMMUNOCORE HOLDINGS PLC-ADR IMCR 2022-08-12 13:15:04 UTC 1.6001 0.7199 300000
IMMUNOCORE HOLDINGS PLC-ADR IMCR 2022-08-12 12:45:04 UTC 1.6001 0.7199 300000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin
Blackstone Alternative Investment Funds- Blackstone Alternative Multi-Strategy Fund IMCR -2000.0 shares, $-59800.0 2022-03-31 N-PORT

Elevate your investments